Real-world trends in radiotherapy modalities for esophageal cancer: analysis of a nationwide claims database in Japan
- 1Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Miyagi Japan
- 2Department of Radiation Oncology, South Miyagi Medical Center, 38-1 Nishi, Ogawara, Shibata, 989-1253 Miyagi Japan
- 3Department of Radiology, Faculty of Medicine, University of Yamanashi, 4-4-37 Takeda, Kofu, 400-8510 Yamanashi Japan
Abstract
Background: Recently, the application of Intensity-Modulated Radiotherapy (IMRT) and changes in fractionation schedules have been increasingly introduced in radiotherapy practice for esophageal cancer. However, the extent of their adoption and prevalence in real-world clinical practice remains unclear. This study aimed to describe nationwide trends in radiotherapy for esophageal cancer using a large-scale health insurance claims database.
Methods: Using the DeSC database, we identified patients newly diagnosed with esophageal cancer between April 2017 and March 2023. Patients treated with definitive radiotherapy (defined as 25–35 treatment days in patients without distant metastasis) were selected. We analyzed temporal trends in radiotherapy, regional differences, and the incidence of radiation pneumonitis.
Results: Among patients with an identified initial treatment, the proportion of radiotherapy declined from 28.6% in 2017 to 19.6% in 2022. A total of 1,324 patients were included in the definitive radiotherapy group. The use of IMRT increased substantially from 10.7% in 2017 to 44.9% in 2022. Regarding fractionation, treatments of 25–28 days increased from 25.0% to 35.9%, while those of 31–35 days decreased. While CDDP/5-FU remained the dominant concurrent chemotherapy, its proportion declined as other platinum-based regimens increased. Urban facilities showed significantly higher implementation of Image-Guided Radiotherapy (IGRT) compared with rural facilities. The cumulative incidence of hospitalization for radiation pneumonitis at 12 months was 1.5%. The cumulative incidence was not significantly altered by IMRT use (sHR: 0.32, p = 0.13), whereas it was lower in patients receiving IGRT (sHR: 0.39, p = 0.04).
Conclusions: This nationwide study demonstrated increased use of advanced techniques including IMRT and IGRT, and shorter fractionation schedules in radiotherapy for esophageal cancer in Japanese clinical practice.
Related
- Hospital-Based Incidence Trends of Thyroid Cancer in Poland: Temporal Trends, Regional Disparities and Demographic Characteristics Based on a Nationwide Hospital Discharge Database (2012-2024).
- Age‐Specific Temporal Trends and Climate‐Associated Seasonality of Appendectomy in Japan: A Nationwide Population‐Based Study Using the National Database
- Salivary glands auto-segmentation in head and neck radiotherapy: imaging modalities, models, and clinical relevance
- Global trends in young and older adult esophageal cancer burden from 1990 to 2021 : An observational analysis for the Global Burden of Disease study 2021
- Real‐World Treatment Escalation Patterns of Biologics and Functional Endoscopic Sinus Surgery in Chronic Rhinosinusitis (CRS): A Nationwide Database Study
BibTeX
@article{takeda2026realworld,
title = {{Real-world trends in radiotherapy modalities for esophageal cancer: analysis of a nationwide claims database in Japan}},
author = {Kazuya Takeda and Shinsaku Okuda and Rei Umezawa and Takaya Yamamoto and Noriyoshi Takahashi and Hiroshi Onishi and Keiichi Jingu},
journal = {Esophagus},
year = {2026},
month = aug,
doi = {10.1007/s10388-026-01248-6},
url = {https://doi.org/10.1007/s10388-026-01248-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Real-world trends in radiotherapy modalities for esophageal cancer: analysis of a nationwide claims database in Japan
AU - Kazuya Takeda
AU - Shinsaku Okuda
AU - Rei Umezawa
AU - Takaya Yamamoto
AU - Noriyoshi Takahashi
AU - Hiroshi Onishi
AU - Keiichi Jingu
PY - 2026
DA - 2026/08/31
JO - Esophagus
DO - 10.1007/s10388-026-01248-6
UR - https://doi.org/10.1007/s10388-026-01248-6
AB - Background: Recently, the application of Intensity-Modulated Radiotherapy (IMRT) and changes in fractionation schedules have been increasingly introduced in radiotherapy practice for esophageal cancer. However, the extent of their adoption and prevalence in real-world clinical practice remains unclear. This study aimed to describe nationwide trends in radiotherapy for esophageal cancer using a large-scale health insurance claims database. Methods: Using the DeSC database, we identified patients newly diagnosed with esophageal cancer between April 2017 and March 2023. Patients treated with definitive radiotherapy (defined as 25–35 treatment days in patients without distant metastasis) were selected. We analyzed temporal trends in radiotherapy, regional differences, and the incidence of radiation pneumonitis. Results: Among patients with an identified initial treatment, the proportion of radiotherapy declined from 28.6% in 2017 to 19.6% in 2022. A total of 1,324 patients were included in the definitive radiotherapy group. The use of IMRT increased substantially from 10.7% in 2017 to 44.9% in 2022. Regarding fractionation, treatments of 25–28 days increased from 25.0% to 35.9%, while those of 31–35 days decreased. While CDDP/5-FU remained the dominant concurrent chemotherapy, its proportion declined as other platinum-based regimens increased. Urban facilities showed significantly higher implementation of Image-Guided Radiotherapy (IGRT) compared with rural facilities. The cumulative incidence of hospitalization for radiation pneumonitis at 12 months was 1.5%. The cumulative incidence was not significantly altered by IMRT use (sHR: 0.32, p = 0.13), whereas it was lower in patients receiving IGRT (sHR: 0.39, p = 0.04). Conclusions: This nationwide study demonstrated increased use of advanced techniques including IMRT and IGRT, and shorter fractionation schedules in radiotherapy for esophageal cancer in Japanese clinical practice.
SN - 1612-9059
SN - 1612-9067
ER -